August 17, 2020 - McKesson Corporation announced it will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed (OWS) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. Vaccines and related supplies will be delivered to point-of-care … [Read more...]
Sanofi, GSK selected for Operation Warp Speed to supply U.S. government with 100 million doses of COVID-19 vaccine
July 31, 2020 – Sanofi (Paris, France) and GSK (London, UK) announced a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine. The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza … [Read more...]
Pfizer, BioNTech to supply Japan with 120 million doses of MRNA-based COVID-19 vaccine candidate
July 31, 2020 – Pfizer (New York, NY) and BioNTech SE (Germany) announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV2 (the virus that causes COVID-19), subject to clinical success and regulatory approval, beginning in 2021. Financial details of the … [Read more...]
Pfizer, BioNTech announce agreement with U.S. government for up to 600 million doses of COVID-19 vaccine candidate
July 22, 2020 – Pfizer Inc. (New York, NY) and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) to meet the U.S. government’s “Operation Warp Speed” program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021. Under the agreement, the U.S. government … [Read more...]
Thermo Fisher Scientific’s response to COVID-19 continues to expand to support development, production of therapeutics, vaccines
July 20, 2020 – Thermo Fisher Scientific Inc. (Waltham, MA) continues to expand global capacity and capabilities across its pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects … [Read more...]
Pfizer, Biontech granted FDA Fast Track designation for two investigational MRNA-based vaccine candidates for SARS-COV-2
Pfizer Inc. (New York, NY) and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their mRNA-based vaccine program being developed to help protect against SARS-CoV-2 (the virus that causes COVID-19), received Fast Track designation from the U.S. Food and Drug Administration (FDA). The two vaccine candidates are currently being … [Read more...]